nta software zetaview software version 8.02.31 (Particle Metrix)
90
Structured Review
Particle Metrix
nta software zetaview software version 8.02.31
Nta Software Zetaview Software Version 8.02.31, supplied by Particle Metrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nta+software+zetaview+software+version+8%2E02%2E31/nta+software+zetaview+8+02+28/pm39454304-103-7-13
Average 90 stars, based on 1 article reviews
Nta Software Zetaview Software Version 8.02.31, supplied by Particle Metrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nta+software+zetaview+software+version+8%2E02%2E31/nta+software+zetaview+8+02+28/pm39454304-103-7-13
Average 90 stars, based on 1 article reviews
nta software zetaview software version 8.02.31 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Histone deacetylase inhibition disrupts the molecular signature of the glioblastoma secretome related to extracellular vesicle-associated proteins and targets RAB7a and RAB14 in vitro. Article Snippet: Glioblastoma (GBM) is the most aggressive brain tumor with a poor prognosis.. While Histone Deacetylase inhibitors have shown promising results in inhibiting cancer cell invasion and promoting apoptosis, their effects on GBM secretion, specifically focusing on extracellular vesicles (EVs) secretion, remain largely unexplored.. Using label-free NANOLC-MS/MS methodology, we identified significant changes in the abundance of membrane traffic regulatory proteins in the secretome of U87MG cells after the treatment with the HDAC inhibitor Trichostatin A (TSA). Software:Article Title: Histone deacetylase inhibition disrupts the molecular signature of the glioblastoma secretome related to extracellular vesicle-associated proteins and targets RAB7a and RAB14 in vitro. Article Snippet: Glioblastoma (GBM) is the most aggressive brain tumor with a poor prognosis.. While Histone Deacetylase inhibitors have shown promising results in inhibiting cancer cell invasion and promoting apoptosis, their effects on GBM secretion, specifically focusing on extracellular vesicles (EVs) secretion, remain largely unexplored.. Using label-free NANOLC-MS/MS methodology, we identified significant changes in the abundance of membrane traffic regulatory proteins in the secretome of U87MG cells after the treatment with the HDAC inhibitor Trichostatin A (TSA). |